Phreesia, Inc. $PHR Stock Holdings Lowered by ArrowMark Colorado Holdings LLC

ArrowMark Colorado Holdings LLC cut its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 15.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 351,542 shares of the company’s stock after selling 64,202 shares during the period. ArrowMark Colorado Holdings LLC owned approximately 0.59% of Phreesia worth $8,268,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of PHR. Vanguard Group Inc. boosted its holdings in shares of Phreesia by 8.3% in the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock worth $134,177,000 after buying an additional 437,462 shares during the period. New York State Common Retirement Fund increased its holdings in shares of Phreesia by 727.1% in the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock valued at $3,219,000 after purchasing an additional 120,309 shares during the period. Squarepoint Ops LLC lifted its position in shares of Phreesia by 243.6% in the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after purchasing an additional 71,553 shares in the last quarter. Bessemer Group Inc. lifted its position in Phreesia by 1,065.9% in the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock worth $13,043,000 after buying an additional 506,954 shares in the last quarter. Finally, Boston Partners boosted its position in Phreesia by 165.1% during the second quarter. Boston Partners now owns 130,060 shares of the company’s stock valued at $3,702,000 after purchasing an additional 81,006 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Stock Performance

Shares of NYSE:PHR opened at $10.98 on Monday. Phreesia, Inc. has a twelve month low of $10.77 and a twelve month high of $32.76. The business has a fifty day moving average of $13.70 and a 200-day moving average of $19.06. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44. The firm has a market cap of $661.68 million, a PE ratio of -109.74 and a beta of 0.67.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PHR. Needham & Company LLC reaffirmed a “buy” rating and set a $35.00 price objective on shares of Phreesia in a research report on Monday, December 8th. Mizuho set a $22.00 target price on shares of Phreesia in a research note on Wednesday, February 4th. Barclays dropped their price objective on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 16th. Zacks Research lowered shares of Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Finally, Citigroup cut their price target on Phreesia from $29.00 to $25.00 and set a “buy” rating for the company in a report on Friday, January 9th. Seventeen equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $29.12.

Insiders Place Their Bets

In related news, insider Evan Roberts sold 6,268 shares of the firm’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $102,544.48. Following the completion of the sale, the insider owned 826,554 shares of the company’s stock, valued at $13,522,423.44. This trade represents a 0.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Balaji Gandhi sold 4,687 shares of the business’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $76,679.32. Following the sale, the chief financial officer owned 150,569 shares of the company’s stock, valued at approximately $2,463,308.84. The trade was a 3.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 60,766 shares of company stock valued at $1,013,817 over the last quarter. Company insiders own 5.50% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.